“Neoadjuvant chemotherapy is the preferred approach based on the available level of evidence. However, for patients who do not receive neoadjuvant chemotherapy, these data lend further support to considering adjuvant chemotherapy,” he said.
News
Adjuvant chemo ups survival of patients with locally advanced bladder cancer
